REST and neuroblastoma: REST expression may have pro-oncogenic activity in nervous tumors and is found consistently upregulated in neuroblastomas and medulloblastomas (91, 92), while in small-cell lung carcinomas, loss of REST activity is observed and related to NE phenotype (93).